Location: Home
  • search
  • go
  • Relate News
  • 3/31/2022Recent Executive Moves
  • 3/31/2022China's Ministry of Science and Technology Publishes Draft Rules on th...
  • 3/31/2022More JAK Therapies for Atopic Dermatitis Expected in China (PharmaDJ)
  • 3/30/2022Brii Bio Enters Strategic Partnership with Sinopharm to Advance Commer...
  • 3/30/2022IQVIA: Chinese Retail Pharmacy Sales Up 0.6% in Q4/2021
  • 3/30/2022IQVIA: Chinese Biopharma Investment Hotspots and Sustainability
  • 3/29/2022NHC and NMPA Solicits Comments on Two Documents on Temporary Import Wo...
  • 3/28/2022Innovent and Lilly Expand Strategic Partnership in Oncology
  • 3/24/2022Eli Lilly/Innovent Announce Lung Cancer Drug Rejection by FDA Citing...
  • 3/24/2022What Could Happen Next for U.S.-listed Chinese Stocks? (PharmaDJ)
  • 3/24/2022Bracing for Volume-Based Procurement in China (Simon Kucher)
  • 3/22/2022PharmaDJ's China Deals Tracker: February 2022
  • 3/22/2022Transcenta Announces Global Clinical Collaboration with BMS to Evaluat...
  • 3/21/2022China's Triastek and Siemens Strive to Accelerate Digital Transformati...
  • 3/21/2022As AZ Sounds the Slowdown Alarm in China, Jefferies Beats the Drum for...
  • 3/18/2022Lynk and Simcere Enter Strategic Commercialization Partnership in Chin...
  • 3/18/2022Sinohealth: Chinese Public Hospital Drug Market Up 10.1% in 2021
  • 3/18/2022Recent Executive Moves
  • 3/16/2022Adagene, Merck Gets FDA Blessing P1b/2 Trial of ADG126/Keytruda Combo
  • 3/16/2022PharmCube: An Analysis of NDAs in China
  • 3/14/2022China Healthcare Investment Now Up To 30% Of Global Total (PharmaDJ)
  • 3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility
  • 3/11/2022CDE Solicits Comments on Two Draft TCM Registration Guidelines
  • 3/11/2022Recent Executive Moves
  • 3/10/2022AmCham Survey, U.S. Firms Less Optimistic About Making New Investments...
  • 3/10/2022SEC Sets Clock for Delisting Chinese Companies Over US Audit Demand (U...
  • 3/9/2022Snapshot of MNC Pharma's China Performance in 2021 (Updated)
  • 3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha
  • 3/9/2022Hanmi to Launch High Blood Pressure Drug Amosartan in China
  • 3/9/2022China Meheco Inks Deal to Market Pfizer's Covid Pill Paxlovid in China
  • Page:74/361 Total number of articles:10807: [First][<<] [72] [73] [74] [75] [76] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group